Learn More About Our Technology

Revolutionary Cardiac Ablation

Ablation Strategies Inc. pioneers MRI-guided stereotactic radioablation for treating refractory atrial fibrillation and ventricular tachycardia. Our innovative technology delivers targeted treatment with unprecedented precision while minimizing exposure to healthy cardiac tissue.

Advanced Technology Platform

Cutting-Edge Treatment Solutions

MRI-Guided Precision

Our MRI-Linac technology provides real-time imaging guidance for accurate target identification and treatment delivery. This advanced imaging capability ensures superior visualization of cardiac structures compared to traditional X-ray based systems.

Minimal Tissue Damage

Stereotactic radioablation delivers high-dose radiation to target lesions while preserving surrounding healthy tissue. Our treatment planning optimizes dose distribution to protect critical cardiac structures and organs at risk.

Single-Fraction Treatment

Patients receive their complete treatment in a single session, eliminating the need for multiple procedures. This streamlined approach reduces overall treatment time and improves patient convenience and outcomes.

Comprehensive Treatment Planning

Our multi-disciplinary team utilizes advanced imaging fusion and inverse treatment planning to create customized ablation strategies. Each treatment plan is meticulously designed to target the specific anatomical source of arrhythmia.

Evidence-Based Protocol

Our treatment approach is grounded in rigorous clinical research and preclinical animal studies demonstrating safety and efficacy. We follow internationally recognized guidelines and best practices in cardiac ablation therapy.

Multi-Center Clinical Trials

Ablation Strategies Inc. is conducting prospective clinical trials at leading academic medical centers to validate our technology. Our research demonstrates promising results in patients who have failed conventional catheter ablation and medication therapy.

Expert Clinical Team

Our physicians include board-certified electrophysiologists and radiation oncologists with extensive experience in cardiac arrhythmia management. We collaborate with independent clinical reviewers to ensure the highest standards of patient care and safety.

Patient-Centered Care

Comprehensive Patient Support

Innovation in Cardiac Care — Precision Treatment — Patient-Focused Solutions

Transforming the treatment of refractory cardiac arrhythmias through advanced MRI-guided stereotactic radioablation technology.

Personalized Treatment PlansEach patient receives a customized ablation strategy based on detailed cardiac imaging and electrophysiological mapping.

Rigorous Quality AssuranceOur treatment plans undergo comprehensive quality assurance testing including phantom-based validation before clinical delivery.

Long-Term Follow-Up CarePatients receive ongoing monitoring and support throughout a structured 12-month follow-up program to assess treatment efficacy and safety.

40M

Americans Affected by Atrial Fibrillation

25Gy

Single-Fraction Radiation Dose

99%

Target Volume Coverage

3

Clinical Trial Centers

Clinical Success Stories

Patient Outcomes & Results

The treatment was remarkably efficient and well-tolerated with minimal side effects. I experienced significant improvement in my arrhythmia symptoms within the first month following the procedure.

Dr. Robert MitchellDr. Robert MitchellCardiologist, Academic Medical Center

This innovative technology offers hope to patients like me who had exhausted all other treatment options. The precision and safety of the MRI-guided approach gave me confidence in the procedure.

Sarah JohnsonSarah JohnsonPatient, Refractory Atrial Fibrillation

Common Questions

Frequently Asked Questions

What is MRI-guided stereotactic radioablation?MRI-guided stereotactic radioablation is an advanced treatment that uses magnetic resonance imaging to precisely target and ablate abnormal cardiac tissue causing arrhythmias. The technology delivers a high dose of radiation in a single fraction while minimizing exposure to healthy heart tissue.

Who is a candidate for this treatment?Patients with refractory atrial fibrillation or ventricular tachycardia who have failed conventional catheter ablation, medication therapy, or are ineligible for these treatments may be candidates. A comprehensive evaluation by our clinical team determines individual eligibility.

How long does the treatment take?The actual treatment delivery typically takes 20-30 minutes, though the entire appointment including imaging and setup may take 2-3 hours. The entire treatment course is completed in a single session.

What are the potential side effects?Our rigorous treatment planning and quality assurance protocols are designed to minimize side effects. Most patients tolerate the procedure well with minimal complications when appropriate patient selection criteria are met.

What is the follow-up care process?Patients receive monthly follow-up evaluations for the first year, with comprehensive cardiac monitoring and arrhythmia assessment at 1, 3, 6, and 12 months post-treatment. Our team tracks treatment efficacy and ensures optimal long-term outcomes.